Neuroinflammatory changes negatively impact on LTP: A focus on IL-1β

Brain Research

Volumn 1621, Issue , 2015, Pages 197-204

  Lynch, Marina A ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Inflammatory cytokines; Interleukin 1; Long term potentiation; Neuroinflammation

Indexed keywords

4 [5 (4 CHLOROPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOL 1 YL]BENZENESULFONAMIDE; ACETYLCYSTEINE; CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN; CIGLITAZONE; GLUCAGON LIKE PEPTIDE 1; IBUDILAST; ICOSAPENTAENOIC ACID; INFLAMMASOME; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 6; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR ALPHA; VITAMIN;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ASTROCYTE; BLOOD BRAIN BARRIER; CYTOKINE RELEASE; GRANULE CELL; HIPPOCAMPUS; HUMAN; LONG TERM POTENTIATION; MACROPHAGE ACTIVATION; MEMBRANE PERMEABILITY; MICROGLIA; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PERFORANT NERVE TRACT; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SPATIAL LEARNING; ANIMAL; ENCEPHALITIS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ENCEPHALITIS; HIPPOCAMPUS; HUMANS; INTERLEUKIN-1BETA; LONG-TERM POTENTIATION; MICROGLIA;

EID: 84941600256     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2014.08.040     Document Type: Review

References (106)

1. A. Arranz, C. Doxaki, E. Vergadi, Y. Martinez de la Torre, K. Vaporidi, E.D. Lagoudaki, E. Ieronymaki, A. Androulidaki, M. Venihaki, A.N. Margioris, E.N. Stathopoulos, P.N. Tsichlis, and C. Tsatsanis Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization Proc. Natl. Acad. Sci. U.S.A 109 2012 9517 9522
2. A. Avital, I. Goshen, A. Kamsler, M. Segal, K. Iverfeldt, G. Richter-Levin, and R. Yirmiya Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity Hippocampus 13 2003 826 834
3. R.M. Barrientos, E.A. Higgins, J.C. Biedenkapp, D.B. Sprunger, K.J. Wright-Hardesty, L.R. Watkins, J.W. Rudy, and S.F. Maier Peripheral infection and aging interact to impair hippocampal memory consolidation Neurobiol. Aging 27 2006 723 732
4. R.M. Barrientos, A.M. Hein, M.G. Frank, L.R. Watkins, and S.F. Maier Intracisternal interleukin-1 receptor antagonist prevents postoperative cognitive decline and neuroinflammatory response in aged rats J. Neurosci. 32 2012 14641 14648
5. C.E. Barry, Y. Nolan, R.M. Clarke, A. Lynch, and M.A. Lynch Activation of c-Jun-N-terminal kinase is critical in mediating lipopolysaccharide-induced changes in the rat hippocampus J. Neurochem. 93 2005 221 231
6. P. Bekinschtein, C.A. Oomen, L.M. Saksida, and T.J. Bussey Effects of environmental enrichment and voluntary exercise on neurogenesis, learning and memory, and pattern separation: BDNF as a critical variable? Semin. Cell Dev. Biol. 22 2011 536 542
7. F.P. Bellinger, S. Madamba, and G.R. Siggins Interleukin 1 beta inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus Brain Res. 628 1993 227 234
8. F.P. Bellinger, S.G. Madamba, I.L. Campbell, and G.R. Siggins Reduced long-term potentiation in the dentate gyrus of transgenic mice with cerebral overexpression of interleukin-6 Neurosci. Lett. 198 1995 95 98
9. O. Ben Menachem-Zidon, A. Avital, Y. Ben-Menahem, I. Goshen, T. Kreisel, E.M. Shmueli, M. Segal, T. Ben Hur, and R. Yirmiya Astrocytes support hippocampal-dependent memory and long-term potentiation via interleukin-1 signaling Brain Behav. Immun. 25 2011 1008 1016
10. C.M. Blatteis Neural mechanisms in the pyrogenic and acute-phase responses to interleukin-1 Int. J. Neurosci. 38 1988 223 232
11. A.J. Bruce-Keller, C.L. White, S. Gupta, A.G. Knight, P.J. Pistell, D.K. Ingram, C.D. Morrison, and J.N. Keller NOX activity in brain aging: exacerbation by high fat diet Free Radical Biol. Med. 49 2010 22 30
12. E. Bruel-Jungerman, A. Veyrac, F. Dufour, J. Horwood, S. Laroche, and S. Davis Inhibition of PI3K-Akt signaling blocks exercise-mediated enhancement of adult neurogenesis and synaptic plasticity in the dentate gyrus PLoS One 4 2009 e7901
13. M.P. Butler, J.J. O'Connor, and P.N. Moynagh Dissection of tumor-necrosis factor-alpha inhibition of long-term potentiation (LTP) reveals a p38 mitogen-activated protein kinase-dependent mechanism which maps to early-but not late-phase LTP Neuroscience 124 2004 319 326
14. A. Chawla Control of macrophage activation and function by PPARs Circ. Res. 106 2010 1559 1569
15. J. Chen, J.B. Buchanan, N.L. Sparkman, J.P. Godbout, G.G. Freund, and R.W. Johnson Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system Brain Behav. Immun. 22 2008 301 311
16. V. Chhor, T. Le Charpentier, S. Lebon, M.V. Ore, I.L. Celador, J. Josserand, V. Degos, E. Jacotot, H. Hagberg, K. Savman, C. Mallard, P. Gressens, and B. Fleiss Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro Brain Behav. Immun. 2013
17. Y.X. Chu, Y.Q. Zhang, and Z.Q. Zhao Involvement of microglia and interleukin-18 in the induction of long-term potentiation of spinal nociceptive responses induced by tetanic sciatic stimulation Neurosci. Bull 28 2012 49 60
18. R.M. Clarke, F. O'Connell, A. Lyons, and M.A. Lynch The HMG-CoA reductase inhibitor, atorvastatin, attenuates the effects of acute administration of amyloid-beta1-42 in the rat hippocampus in vivo Neuropharmacology 52 2007 136 145
19. R.M. Clarke, A. Lyons, F. O'Connell, B.F. Deighan, C.E. Barry, N.G. Anyakoha, A. Nicolaou, and M.A. Lynch A pivotal role for interleukin-4 in atorvastatin-associated neuroprotection in rat brain J. Biol. Chem. 283 2008 1808 1817
20. C.A. Colton, and D.M. Wilcock Assessing activation states in microglia CNS Neurol. Disord. Drug Targets 9 2010 174 191
21. D.A. Costello, D.M. O'Leary, and C.E. Herron Agonists of peroxisome proliferator-activated receptor-gamma attenuate the Abeta-mediated impairment of LTP in the hippocampus in vitro Neuropharmacology 49 2005 359 366
22. D.A. Costello, A. Lyons, S. Denieffe, T.C. Browne, F.F. Cox, and M.A. Lynch Long term potentiation is impaired in membrane glycoprotein CD200-deficient mice: a role for Toll-like receptor activation J. Biol. Chem. 286 2011 34722 34732
23. T.R. Cowley, J. O'Sullivan, C. Blau, B.F. Deighan, R. Jones, C. Kerskens, J.C. Richardson, D. Virley, N. Upton, and M.A. Lynch Rosiglitazone attenuates the age-related changes in astrocytosis and the deficit in LTP Neurobiol. Aging 33 2012 162 175
24. F.F. Cox, D. Carney, A.M. Miller, and M.A. Lynch CD200 fusion protein decreases microglial activation in the hippocampus of aged rats Brain Behav. Immun. 26 2012 789 796
25. D. Cumiskey, M.P. Butler, P.N. Moynagh, and J. O'Connor J Evidence for a role for the group I metabotropic glutamate receptor in the inhibitory effect of tumor necrosis factor-alpha on long-term potentiation Brain Res. 1136 2007 13 19
26. D. Cumiskey, B.P. Curran, C.E. Herron, and J.J. O'Connor A role for inflammatory mediators in the IL-18 mediated attenuation of LTP in the rat dentate gyrus Neuropharmacology 52 2007 1616 1623
27. D. Cumiskey, M. Pickering, and J.J. O'Connor Interleukin-18 mediated inhibition of LTP in the rat dentate gyrus is attenuated in the presence of mGluR antagonists Neurosci. Lett. 412 2007 206 210
28. A.J. Cunningham, C.A. Murray, L.A. O'Neill, M.A. Lynch, and J.J. O'Connor Interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro Neurosci. Lett. 203 1996 17 20
29. B. Curran, and J.J. O'Connor The pro-inflammatory cytokine interleukin-18 impairs long-term potentiation and NMDA receptor-mediated transmission in the rat hippocampus in vitro Neuroscience 108 2001 83 90
30. B.P. Curran, H.J. Murray, and J.J. O'Connor A role for c-Jun N-terminal kinase in the inhibition of long-term potentiation by interleukin-1beta and long-term depression in the rat dentate gyrus in vitro Neuroscience 118 2003 347 357
31. J.P. de Rivero Vaccari, W.D. Dietrich, and R.W. Keane Activation and regulation of cellular inflammasomes: gaps in our knowledge for central nervous system injury J. Cereb. Blood Flow Metab. 34 2014 369 375
32. S. Denieffe, R.J. Kelly, C. McDonald, A. Lyons, and M.A. Lynch Classical activation of microglia in CD200-deficient mice is a consequence of blood brain barrier permeability and infiltration of peripheral cells Brain Behav. Immun. 34 2013 86 97
33. S. Denieffe, R.J. Kelly, C. McDonald, A. Lyons, and M.A. Lynch Classical activation of microglia in CD200-deficient mice is a consequence of blood brain barrier permeability and infiltration of peripheral cells Brain Behav. Immun. 34 2013 86 97
34. A. Dunne, and L.A. O'Neill The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense Sci. STKE 2003 (2003, re3.)
35. M.J. Eckert, and W.C. Abraham Physiological effects of enriched environment exposure and LTP induction in the hippocampus in vivo do not transfer faithfully to in vitro slices Learn. Mem. 17 2010 480 484
36. E. Gahtan, and J.B. Overmier Performance more than working memory disrupted by acute systemic inflammation in rats in appetitive tasks Physiol. Behav. 73 2001 201 210
37. J.J. Gallagher, M.E. Finnegan, B. Grehan, J. Dobson, J.F. Collingwood, and M.A. Lynch Modest amyloid deposition is associated with iron dysregulation, microglial activation, and oxidative stress J. Alzheimers Dis. 28 2012 147 161
38. J.J. Gallagher, A.M. Minogue, and M.A. Lynch Impaired performance of female APP/PS1 mice in the Morris water maze is coupled with increased abeta accumulation and microglial activation Neurodegener. Dis. 11 2013 33 41
39. J.P. Godbout, J. Chen, J. Abraham, A.F. Richwine, B.M. Berg, K.W. Kelley, and R.W. Johnson Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system FASEB J. 19 2005 1329 1331
40. S. Gordon Alternative activation of macrophages Nat. Rev. Immunol. 3 2003 23 35
41. I. Goshen, T. Kreisel, H. Ounallah-Saad, P. Renbaum, Y. Zalzstein, T. Ben-Hur, E. Levy-Lahad, and R. Yirmiya A dual role for interleukin-1 in hippocampal-dependent memory processes Psychoneuroendocrinology 32 2007 1106 1115
42. I. Goshen, A. Avital, T. Kreisel, T. Licht, M. Segal, and R. Yirmiya Environmental enrichment restores memory functioning in mice with impaired IL-1 signaling via reinstatement of long-term potentiation and spine size enlargement J. Neurosci. 29 2009 3395 3403
43. R. Griffin, R. Nally, Y. Nolan, Y. McCartney, J. Linden, and M.A. Lynch The age-related attenuation in long-term potentiation is associated with microglial activation J. Neurochem. 99 2006 1263 1272
44. D. Gruber-Schoffnegger, R. Drdla-Schutting, C. Honigsperger, G. Wunderbaldinger, M. Gassner, and J. Sandkuhler Induction of thermal hyperalgesia and synaptic long-term potentiation in the spinal cord lamina I by TNF-alpha and IL-1beta is mediated by glial cells J. Neurosci. 33 2013 6540 6551
45. Y. Hayashi, M. Yoshida, M. Yamato, T. Ide, Z. Wu, M. Ochi-Shindou, T. Kanki, D. Kang, K. Sunagawa, H. Tsutsui, and H. Nakanishi Reverse of age-dependent memory impairment and mitochondrial DNA damage in microglia by an overexpression of human mitochondrial transcription factor a in mice J. Neurosci. 28 2008 8624 8634
46. A.M. Hein, M.R. Stasko, S.B. Matousek, J.J. Scott-McKean, S.F. Maier, J.A. Olschowka, A.C. Costa, and M.K. O'Banion Sustained hippocampal IL-1beta overexpression impairs contextual and spatial memory in transgenic mice Brain Behav. Immun. 24 2010 243 253
47. A.M. Hein, T.J. Zarcone, D.B. Parfitt, S.B. Matousek, D.M. Carbonari, J.A. Olschowka, and M.K. O'Banion Behavioral, structural and molecular changes following long-term hippocampal IL-1beta overexpression in transgenic mice J. Neuroimmune Pharmacol. 7 2012 145 155
48. M.T. Heneka, M.P. Kummer, A. Stutz, A. Delekate, S. Schwartz, A. Vieira-Saecker, A. Griep, D. Axt, A. Remus, T.C. Tzeng, E. Gelpi, A. Halle, M. Korte, E. Latz, and D.T. Golenbock NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice Nature 493 2013 674 678
49. T. Iwai, T. Sawabe, K. Tanimitsu, M. Suzuki, S. Sasaki-Hamada, and J. Oka Glucagon-like peptide-1 protects synaptic and learning functions from neuroinflammation in rodents J. Neurosci. Res. 92 2014 446 454
50. J. Jo, D.J. Whitcomb, K.M. Olsen, T.L. Kerrigan, S.C. Lo, G. Bru-Mercier, B. Dickinson, S. Scullion, M. Sheng, G. Collingridge, and K. Cho Abeta(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3beta Nat. Neurosci. 14 2011 545 547
51. H. Katsuki, S. Nakai, Y. Hirai, K. Akaji, Y. Kiso, and M. Satoh Interleukin-1 beta inhibits long-term potentiation in the CA3 region of mouse hippocampal slices Eur. J. Pharmacol. 181 1990 323 326
52. A. Kelly, and M.A. Lynch Long-term potentiation in dentate gyrus of the rat is inhibited by the phosphoinositide 3-kinase inhibitor, wortmannin Neuropharmacology 39 2000 643 651
53. A. Kelly, A. Lynch, E. Vereker, Y. Nolan, P. Queenan, E. Whittaker, L.A. O'Neill, and M.A. Lynch The anti-inflammatory cytokine, interleukin (IL)-10, blocks the inhibitory effect of IL-1 beta on long term potentiation. A role for JNK J. Biol. Chem. 276 2001 45564 45572
54. A. Kelly, E. Vereker, Y. Nolan, M. Brady, C. Barry, C.E. Loscher, K.H. Mills, and M.A. Lynch Activation of p38 plays a pivotal role in the inhibitory effect of lipopolysaccharide and interleukin-1 beta on long term potentiation in rat dentate gyrus J. Biol. Chem. 278 2003 19453 19462
55. R.J. Kelly, A.M. Minogue, A. Lyons, R.S. Jones, T.C. Browne, D.A. Costello, S. Denieffe, C. O'Sullivan, T.J. Connor, and M.A. Lynch Glial activation in a beta PP/PS1 mice is associated with infiltration of IFN gamma-producing cells J. Alzheimers Dis. 37 2013 63 75
56. M. Kitazawa, D. Cheng, M.R. Tsukamoto, M.A. Koike, P.D. Wes, V. Vasilevko, D.H. Cribbs, and F.M. LaFerla Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal beta-catenin pathway function in an Alzheimer's disease model J. Immunol. 187 2011 6539 6549
57. M.J. Kluger Fever: role of pyrogens and cryogens Physiol. Rev. 71 1991 93 127
58. A. Kumar, B.A. Stoica, B. Sabirzhanov, M.P. Burns, A.I. Faden, and D.J. Loane Traumatic brain injury in aged animals increases lesion size and chronically alters microglial/macrophage classical and alternative activation states Neurobiol. Aging 34 2013 1397 1411
59. F. Lante, J. Meunier, J. Guiramand, M.C. De Jesus Ferreira, G. Cambonie, R. Aimar, C. Cohen-Solal, T. Maurice, M. Vignes, and G. Barbanel Late N-acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation Hippocampus 18 2008 602 609
60. X. Liu, Z. Wu, Y. Hayashi, and H. Nakanishi Age-dependent neuroinflammatory responses and deficits in long-term potentiation in the hippocampus during systemic inflammation Neuroscience 216 2012 133 142
61. D.J. Loane, B.F. Deighan, R.M. Clarke, R.J. Griffin, A.M. Lynch, and M.A. Lynch Interleukin-4 mediates the neuroprotective effects of rosiglitazone in the aged brain Neurobiol. Aging 30 2009 920 931
62. P.E. Lonergan, D.S. Martin, D.F. Horrobin, and M.A. Lynch Neuroprotective effect of eicosapentaenoic acid in hippocampus of rats exposed to gamma-irradiation J. Biol. Chem. 277 2002 20804 20811
63. C.E. Loscher, K.H. Mills, and M.A. Lynch Interleukin-1 receptor antagonist exerts agonist activity in the hippocampus independent of the interleukin-1 type I receptor J. Neuroimmunol. 137 2003 117 124
64. A.M. Lynch, C. Walsh, A. Delaney, Y. Nolan, V.A. Campbell, and M.A. Lynch Lipopolysaccharide-induced increase in signalling in hippocampus is abrogated by IL-10 - a role for IL-1 beta? J. Neurochem. 88 2004 635 646
65. A.M. Lynch, D.J. Loane, A.M. Minogue, R.M. Clarke, D. Kilroy, R.E. Nally, O.J. Roche, F. O'Connell, and M.A. Lynch Eicosapentaenoic acid confers neuroprotection in the amyloid-beta challenged aged hippocampus Neurobiol. Aging 28 2007 845 855
66. M.A. Lynch Age-related impairment in long-term potentiation in hippocampus: a role for the cytokine, interleukin-1 beta? Prog. Neurobiol 56 1998 571 589
67. M.A. Lynch Lipoic acid confers protection against oxidative injury in non-neuronal and neuronal tissue Nutr. Neurosci. 4 2001 419 438
68. M.A. Lynch Long-term potentiation and memory Physiol. Rev. 84 2004 87 136
69. M.A. Lynch The multifaceted profile of activated microglia Mol. Neurobiol. 40 2009 139 156
70. M.A. Lynch Age-related neuroinflammatory changes negatively impact on neuronal function Front Aging Neurosci 1 2010 6
71. A. Lyons, R.J. Griffin, C.E. Costelloe, R.M. Clarke, and M.A. Lynch IL-4 attenuates the neuroinflammation induced by amyloid-beta in vivo and in vitro J. Neurochem. 101 2007 771 781
72. N. Maggio, E. Shavit-Stein, A. Dori, I. Blatt, and J. Chapman Prolonged systemic inflammation persistently modifies synaptic plasticity in the hippocampus: modulation by the stress hormones Front. Mol. Neurosci 6 2013 46
73. F.O. Maher, R.M. Clarke, A. Kelly, R.E. Nally, and M.A. Lynch Interaction between interferon gamma and insulin-like growth factor-1 in hippocampus impacts on the ability of rats to sustain long-term potentiation J. Neurochem. 96 2006 1560 1571
74. S. Mandrekar-Colucci, J.C. Karlo, and G.E. Landreth Mechanisms underlying the rapid peroxisome proliferator-activated receptor-gamma-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease J. Neurosci. 32 2012 10117 10128
75. L.J. Mawhinney, J.P. de Rivero Vaccari, G.A. Dale, R.W. Keane, and H.M Bramlett Heightened inflammasome activation is linked to age-related cognitive impairment in Fischer 344 rats BMC Neurosci 12 2011 123
76. B.M. McGahon, D.S. Martin, D.F. Horrobin, and M.A. Lynch Age-related changes in LTP and antioxidant defenses are reversed by an alpha-lipoic acid-enriched diet Neurobiol. Aging 20 1999 655 664
77. V. Mendoza-Fernandez, R.D. Andrew, and C. Barajas-Lopez Interferon-alpha inhibits long-term potentiation and unmasks a long-term depression in the rat hippocampus Brain Res. 885 2000 14 24
78. J. Minkiewicz, J.P. de Rivero Vaccari, and R.W Keane Human astrocytes express a novel NLRP2 inflammasome Glia 61 2013 1113 1121
79. A.M. Minogue, J.P. Barrett, and M.A. Lynch LPS-induced release of IL-6 from glia modulates production of IL-1 beta in a JAK2-dependent manner J. Neuroinflammation 9 2012 126
80. A.M. Minogue, R.S. Jones, R.J. Kelly, C.L. McDonald, T.J. Connor, and M.A. Lynch Age-associated dysregulation of microglial activation is coupled with enhanced blood-brain barrier permeability and pathology in APP/PS1 mice Neurobiol. Aging 35 2014 1442 1452
81. R.E. Mirza, M.M. Fang, W.J. Ennis, and T.J. Koh Blocking interleukin-1beta induces a healing-associated wound macrophage phenotype and improves healing in type 2 diabetes Diabetes 62 2013 2579 2587
82. T. Mizuno, T. Kurotani, Y. Komatsu, J. Kawanokuchi, H. Kato, N. Mitsuma, and A. Suzumura Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia Neuropharmacology 46 2004 404 411
83. D.M. Mosser The many faces of macrophage activation J. Leukocyte Biol. 73 2003 209 212
84. N. Murphy, T.R. Cowley, J.C. Richardson, D. Virley, N. Upton, D. Walter, and M.A. Lynch The neuroprotective effect of a specific P2X(7) receptor antagonist derives from its ability to inhibit assembly of the NLRP3 inflammasome in glial cells Brain Pathol. 22 2012 295 306
85. C.A. Murray, and M.A. Lynch Evidence that increased hippocampal expression of the cytokine interleukin-1 beta is a common trigger for age- and stress-induced impairments in long-term potentiation J. Neurosci. 18 1998 2974 2981
86. C.A. Murray, and M.A. Lynch Dietary supplementation with vitamin E reverses the age-related deficit in long term potentiation in dentate gyrus J. Biol. Chem. 273 1998 12161 12168
87. Y. Nolan, F.O. Maher, D.S. Martin, R.M. Clarke, M.T. Brady, A.E. Bolton, K.H. Mills, and M.A. Lynch Role of interleukin-4 in regulation of age-related inflammatory changes in the hippocampus J. Biol. Chem. 280 2005 9354 9362
88. M.S. Oitzl, H. van Oers, B. Schobitz, and E.R. de Kloet Interleukin-1 beta, but not interleukin-6, impairs spatial navigation learning Brain Res. 613 1993 160 163
89. C.R. Pugh, J.D. Johnson, D. Martin, J.W. Rudy, S.F. Maier, and L.R. Watkins Human immunodeficiency virus-1 coat protein gp120 impairs contextual fear conditioning: a potential role in AIDS related learning and memory impairments Brain Res. 861 2000 8 15
90. C.R. Pugh, K. Kumagawa, M. Fleshner, L.R. Watkins, S.F. Maier, and J.W. Rudy Selective effects of peripheral lipopolysaccharide administration on contextual and auditory-cue fear conditioning Brain Behav. Immun. 12 1998 212 229
91. C.R. Pugh, K.T. Nguyen, J.L. Gonyea, M. Fleshner, L.R. Wakins, S.F. Maier, and J.W. Rudy Role of interleukin-1 beta in impairment of contextual fear conditioning caused by social isolation Behav. Brain Res. 106 1999 109 118
92. F.M. Ross, S.M. Allan, N.J. Rothwell, and A. Verkhratsky A dual role for interleukin-1 in LTP in mouse hippocampal slices J. Neuroimmunol. 144 2003 61 67
93. H. Schneider, F. Pitossi, D. Balschun, A. Wagner, A. del Rey, and H.O. Besedovsky A neuromodulatory role of interleukin-1beta in the hippocampus Proc. Natl. Acad. Sci. U.S.A 95 1998 7778 7783
94. K.N. Shaw, S. Commins, and S.M. O'Mara Lipopolysaccharide causes deficits in spatial learning in the watermaze but not in BDNF expression in the rat dentate gyrus Behav. Brain Res. 124 2001 47 54
95. S. Spulber, T. Bartfai, and M. Schultzberg IL-1/IL-1ra balance in the brain revisited - evidence from transgenic mouse models Brain Behav. Immun. 23 2009 573 579
96. M. Stein, S. Keshav, N. Harris, and S. Gordon Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation J. Exp. Med. 176 1992 287 292
97. Y. Suzuki, J. Claflin, X. Wang, A. Lengi, and T. Kikuchi Microglia and macrophages as innate producers of interferon-gamma in the brain following infection with Toxoplasma gondii Int. J. Parasitol. 35 2005 83 90
98. V. Tancredi, C. Zona, F. Velotti, F. Eusebi, and A. Santoni Interleukin-2 suppresses established long-term potentiation and inhibits its induction in the rat hippocampus Brain Res. 525 1990 149 151
99. L. Tong, G.A. Prieto, E.A. Kramar, E.D. Smith, D.H. Cribbs, G. Lynch, and C.W. Cotman Brain-derived neurotrophic factor-dependent synaptic plasticity is suppressed by interleukin-1beta via p38 mitogen-activated protein kinase J. Neurosci. 32 2012 17714 17724
100. J. Tschopp, F. Martinon, and K. Burns NALPs: a novel protein family involved in inflammation Nat. Rev. Mol. Cell Biol. 4 2003 95 104
101. E. Vereker, V. Campbell, E. Roche, E. McEntee, and M.A. Lynch Lipopolysaccharide inhibits long term potentiation in the rat dentate gyrus by activating caspase-1 J. Biol. Chem. 275 2000 26252 26258
102. E. Vereker, E. O'Donnell, and M.A. Lynch The inhibitory effect of interleukin-1beta on long-term potentiation is coupled with increased activity of stress-activated protein kinases J. Neurosci. 20 2000 6811 6819
103. E. Vereker, E. O'Donnell, A. Lynch, A. Kelly, Y. Nolan, and M.A. Lynch Evidence that interleukin-1beta and reactive oxygen species production play a pivotal role in stress-induced impairment of LTP in the rat dentate gyrus Eur. J. Neurosci. 14 2001 1809 1819
104. J.G. Walsh, D.A. Muruve, and C. Power Inflammasomes in the CNS Nat. Rev. Neurosci. 15 2014 84 97
105. Q. Wang, J. Wu, M.J. Rowan, and R. Anwyl Beta-amyloid inhibition of long-term potentiation is mediated via tumor necrosis factor Eur. J. Neurosci. 22 2005 2827 2832
106. H. Xiong, J. Boyle, M. Winkelbauer, S. Gorantla, J. Zheng, A. Ghorpade, Y. Persidsky, K.A. Carlson, and H.E. Gendelman Inhibition of long-term potentiation by interleukin-8: implications for human immunodeficiency virus-1-associated dementia J. Neurosci. Res. 71 2003 600 607